In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.
AUTOR(ES)
Henriksson, P
RESUMO
The in vivo production of prostacyclin and thromboxane was monitored by measuring their major urinary metabolites 2,3-dinor-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in ten patients with acute myocardial infarction, five on standard treatment and five receiving prostacyclin infusion. During acute myocardial infarction excretion of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha, measured by a gas chromatography-mass spectrometry method with deuterated internal standards, was significantly increased. This indicates that thromboxane and prostacyclin synthesis are increased during the development of acute myocardial infarction. The excretion data for 2,3-dinor-thromboxane B2 showed that after administration of aspirin there was less pronounced and more variable inhibition than expected. Prostacyclin infusion did not markedly affect the excretion of the thromboxane metabolite.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1236759Documentos Relacionados
- Prostacyclin infusion in patients with acute myocardial infarction.
- Epoprostenol sodium (prostacyclin) infusion in acute myocardial infarction.
- Primary coronary angioplasty in patients with acute myocardial infarction.
- Role of sublingual nitroglycerin in patients with acute myocardial infarction.
- Haemodynamic effects of morphine in patients with acute myocardial infarction.